IPM clocks Rs 7294 crores revenue in January 2015

31 corporates have shown growth more than 10 per cent amongst the top 50

In January 2015, the Indian Pharma Market (IPM) has clocked Rs 7294 crores in January 2015. It has grown at 12.7 per cent in the said month. Amongst the top 10, Ranbaxy grew by 28 per cent followed by Pfizer at 25.8 per cent and Abbott at 15.1 per cent. 24 corporate have crossed the growth of IPM for the month of January 2015 amongst top 50. Amongst the top 50 corporate, Akumentis has the highest growth of 68.6 per cent followed by Ranbaxy at 28 per cent and JBCPL at 27.3 per cent. 31 corporates have shown growths more than 10 per cent amongst the top 50.

Amongst the 11-20 ranked corporate, Sanofi has the highest growth of 25.1 per cent followed by Macleods and Torrent at 25 per cent and Glenmark at 21.3 per cent. Amongst the 51-60 ranked corporates, Panacea grows at 32.5 per cent followed by Systopic at 20.1 per cent and Centaur at 15.1 per cent. Amongst the 61-70 ranked corporates, Boehringer grew by 70.4 per cent followed by TTK at 25.4 per cent and Tablets India at 18.9 per cent.